AbGenomics signs first Taiwan biotech contract with foreign firm

06/8/2005 | BiotechEast

AbGenomics of Taiwan said it has signed the island's first contract with a major pharmaceutical company, with Boehringer Ingelheim International to license AbGenomics' antibodies. The announcement said the collaboration would focus first on developing therapies for autoimmune diseases, with Boehringer responsible for development.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX